Retapamulin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01256 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 46 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hordeolum | KG + DL |
| 2 | staphylococcal scalded skin syndrome | KG + DL |
| 3 | cysticercosis | KG + DL |
| 4 | esophageal candidiasis | KG + DL |
| 5 | coenurosis | KG + DL |
| 6 | intestinal helminthiasis | KG + DL |
| 7 | fascioliasis | KG + DL |
| 8 | candidiasis, invasive | KG + DL |
| 9 | congenital candidiasis | KG + DL |
| 10 | neonatal candidiasis | KG + DL |
| 11 | candida glabrata | KG + DL |
| 12 | toxin-mediated infectious botulism | KG + DL |
| 13 | inhalational botulism | KG + DL |
| 14 | cutaneous candidiasis | KG + DL |
| 15 | Clostridium infectious disease | KG + DL |
| 16 | opisthorchiasis | KG + DL |
| 17 | giardiasis | KG + DL |
| 18 | disseminated candidiasis | KG + DL |
| 19 | candidemia | KG + DL |
| 20 | dicrocoeliasis | KG + DL |
| 21 | necatoriasis | KG + DL |
| 22 | paragonimiasis | KG + DL |
| 23 | monieziasis | KG + DL |
| 24 | hymenolepiasis | KG + DL |
| 25 | acanthocephaliasis | KG + DL |
| 26 | echinostomiasis | KG + DL |
| 27 | fascioloidiasis | KG + DL |
| 28 | clonorchiasis | KG + DL |
| 29 | fasciolopsiasis | KG + DL |
| 30 | metagonimiasis | KG + DL |
| 31 | helminthiasis, animal | KG + DL |
| 32 | ocular toxoplasmosis | KG + DL |
| 33 | angiostrongyliasis | KG + DL |
| 34 | Cestode infectious disease | KG + DL |
| 35 | otomycosis | KG + DL |
| 36 | gnathomiasis | KG + DL |
| 37 | punctate epithelial keratoconjunctivitis | KG + DL |
| 38 | secondary vasculitis | KG + DL |
| 39 | fusariosis | KG + DL |
| 40 | unclassified vasculitis | KG + DL |
| 41 | parasitic skin disease | KG + DL |
| 42 | predominantly small-vessel vasculitis | KG + DL |
| 43 | trombiculiasis | KG + DL |
| 44 | synovium cancer | KG + DL |
| 45 | vulvovaginal candidiasis | KG + DL |
| 46 | pleural empyema (disease) | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.